Medical Imaging Continuum: Path Forward for Advancing the Uses of Medical Imaging in the Development of New Biopharmaceutical Products

2 - 3 October 2008, Bethesda, United States

Introduction

This meeting will give stakeholders an opportunity to influence the advancement of regulatory guidance by the US Food and Drug Administration (FDA) and other regulatory agencies expected circa 2011. This effort is currently in progress with PhRMA, the Extended PhRMA Imaging Group, CORAR, MICAA and many other stakeholders who are shaping best practices for standardizing medical imaging in clinical trials, including academia, professional imaging societies, non-profit consortia, governmental agencies, and regulatory authorities.